her2 type breast cancer: the aretta study
Published 3 years ago • 106 plays • Length 1:05:24Download video MP4
Download video MP3
Similar videos
-
4:31
study of atezolizumab with pertuzumab and trastuzumab in her2- positive metastatic breast cancer
-
5:21
study of neratinib for patients with her2-positive breast cancer with brain metastases
-
1:17
clinical outcomes in women with metastatic her2-low breast cancer in the real world
-
4:27
study of immunotherapy combinations for patients with her2-positive metastatic breast cancer
-
5:46
adjuvant trastuzumab emtansine vs paclitaxel and trastuzumab for her2-positive breast cancer
-
49:09
metastatic breast cancer forum 2018: her2-positive breast cancer | dana-farber cancer institute
-
13:08
her2 positive breast cancer: everything you must know
-
25:14
metastatic her2 negative breast cancer: emerging novel treatment strategies
-
4:14
study of gdc-0084 with trastuzumab in her2-positive breast cancer with brain metastases
-
3:19
study of targeted therapy for her2-positive metastatic breast cancer
-
32:54
raising the bar in her2-positive breast cancer
-
1:29
tuxedo-1: trastuzumab deruxtecan for the treatment of her2-positive breast cancer brain metastases
-
5:57
phase 3 study shows her2 therapy clinically meaningful for metastatic breast cancer patients
-
7:30
#esmo21 expert video report on her2-positive metastatic breast cancer
-
1:36
an overview of the meribel study in her2-negative breast cancer
-
30:57
treatment updated for her2 positive breast cancer: changing paradigms
-
3:58
promise breast cancer clinical trial
-
8:21
extended adjuvant therapy for her2-positive breast cancer
-
46:51
her2 in breast cancer: testing guidelines and new treatment approaches